ZYNERBA PHARMACEUTICALS INC has a total of 61 patent applications. Its first patent ever was published in 2007. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and medical technology are MACGREGOR ALEXANDER, MERCK HDAC RES LLC and TIANJIN TASLY GROUP CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 21 | |
#2 | EPO (European Patent Office) | 9 | |
#3 | WIPO (World Intellectual Property Organization) | 6 | |
#4 | Canada | 5 | |
#5 | Australia | 3 | |
#6 | Brazil | 3 | |
#7 | Hungary | 3 | |
#8 | Israel | 3 | |
#9 | Jordan | 3 | |
#10 | Republic of Korea | 3 | |
#11 | Hong Kong | 1 | |
#12 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Medical technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Special acyclic compounds | |
#5 | Acyclic or carbocyclic compounds | |
#6 | Syringes |
# | Name | Total Patents |
---|---|---|
#1 | Gutterman Donna | 32 |
#2 | Messenheimer John | 27 |
#3 | Sebree Terri | 26 |
#4 | Golinski Miroslaw Jerzy | 19 |
#5 | Stinchcomb Audra Lynn | 18 |
#6 | Tich Nancy | 17 |
#7 | Hammell Dana Carmel | 16 |
#8 | Bonn-Miller Marcel | 12 |
#9 | Howard Jeffrey Lynn | 10 |
#10 | Smith Ted | 9 |
Publication | Filing date | Title |
---|---|---|
WO2021055499A1 | Treatment of behavioral impairment in developmental and epileptic encephalopathy | |
WO2020121260A1 | Treatment of 22q11.2 deletion syndrome with cannabidiol | |
AU2018343256A1 | Treatment of Fragile X Syndrome with cannabidiol | |
KR20200055067A | Synthetic transdermal cannabidiol for the treatment of focal epilepsy in adults | |
BR112020003025A2 | methods of treating osteoarthritis with cannabidiol transdermal gel |